Evidence map›Paper›PMID 33067514›Full record

ArticleCommunications biology2020

Focal adhesion ribonucleoprotein complex proteins are major humoral cancer antigens and targets in autoimmune diseases.

Shinichiro Atsumi, Hiroto Katoh, Daisuke Komura, Itaru Hashimoto, Genta Furuya, Hirotomo Koda, Hiroki Konishi, Ryohei Suzuki, Asami Yamamoto, Satsuki Yuba and 7 more

Open access · goldAbstract read
In one paragraph

Article in Communications biology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.3field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 4 institutions in 1 country.

Shinichiro AtsumiDepartment of Preventive Medicine, Graduate School of Medicine, the University of Tokyo, Tokyo, Japan.
Hiroto KatohDepartment of Preventive Medicine, Graduate School of Medicine, the University of Tokyo, Tokyo, Japan. hkat-prm@m.u-tokyo.ac.jp.ORCID 0000-0001-9440-728X
Daisuke KomuraDepartment of Preventive Medicine, Graduate School of Medicine, the University of Tokyo, Tokyo, Japan.ORCID 0000-0002-0038-728X
Itaru HashimotoDepartment of Preventive Medicine, Graduate School of Medicine, the University of Tokyo, Tokyo, Japan.
Genta FuruyaDepartment of Preventive Medicine, Graduate School of Medicine, the University of Tokyo, Tokyo, Japan.
Hirotomo KodaDepartment of Preventive Medicine, Graduate School of Medicine, the University of Tokyo, Tokyo, Japan.
Hiroki KonishiDepartment of Preventive Medicine, Graduate School of Medicine, the University of Tokyo, Tokyo, Japan.
Ryohei SuzukiDepartment of Preventive Medicine, Graduate School of Medicine, the University of Tokyo, Tokyo, Japan.
Asami YamamotoDepartment of Preventive Medicine, Graduate School of Medicine, the University of Tokyo, Tokyo, Japan.
Satsuki YubaDepartment of Preventive Medicine, Graduate School of Medicine, the University of Tokyo, Tokyo, Japan.
Hiroyuki AbeDepartment of Pathology, Graduate School of Medicine, the University of Tokyo, Tokyo, Japan.
Yasushi RinoDepartment of Surgery, Yokohama City University, Kanagawa, Japan.
Takashi OshimaDepartment of Surgery, Yokohama City University, Kanagawa, Japan.
Tetsuo UshikuDepartment of Pathology, Graduate School of Medicine, the University of Tokyo, Tokyo, Japan.
Masashi FukayamaDepartment of Pathology, Graduate School of Medicine, the University of Tokyo, Tokyo, Japan.
Yasuyuki SetoDepartment of Gastrointestinal Surgery, Graduate School of Medicine, the University of Tokyo, Tokyo, Japan.
Shumpei IshikawaDepartment of Preventive Medicine, Graduate School of Medicine, the University of Tokyo, Tokyo, Japan. ishum-prm@m.u-tokyo.ac.jp.ORCID 0000-0003-4392-090X
The University of Tokyo · JPKanagawa Prefectural Hospital Organization · JPTokyo Medical and Dental University · JPYokohama City University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Despite the accumulating evidences of the significance of humoral cancer immunity, its molecular mechanisms have largely remained elusive. Here we show that B-cell repertoire sequencing of 102 clinical gastric cancers and molecular biological analyses unexpectedly reveal that the major humoral cancer antigens are not case-specific neo-antigens but are rather commonly identified as ribonucleoproteins (RNPs) in the focal adhesion complex. These common antigens are shared as autoantigens with multiple autoimmune diseases, suggesting a direct molecular link between cancer- and auto-immunity on the focal adhesion RNP complex. This complex is partially exposed to the outside of cancer cell surfaces, which directly evokes humoral immunity and enables functional bindings of antibodies to cancer cell surfaces in physiological conditions. These findings shed light on humoral cancer immunity in that it commonly targets cellular components fundamental for cytoskeletal integrity and cell movement, pointing to a novel modality of immunotherapy using humoral immunological reactions to cancers.

Indexed as

Focal AdhesionsAntigens, NeoplasmAutoantigensAutoimmune DiseasesBinding SitesB-LymphocytesEpitopes, B-LymphocyteFluorescent Antibody TechniqueHumansImmunity, HumoralModels, BiologicalMultiprotein ComplexesNeoplasmsNucleotide MotifsProtein BindingReceptors, Antigen, B-CellAntigens, NeoplasmAutoantigensEpitopes, B-LymphocyteMultiprotein ComplexesReceptors, Antigen, B-CellRibonucleoproteins

Identifiers

PMID33067514
PMCPMC7567837
OpenAlexW3093395219

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.